ITGB1 and metastatic malignant neoplasm in the lymph nodes: Furthermore, high expression of ITGB1 was correlated with late clinical stages in both cohorts (P = 0.019, P = 0.016, respectively) and with lymph node metastasis but with borderline significance (P = 0.057, P = 0.062, respectively).